REJURAN Intensive Eye Cream c-PDRN - Anti-Aging Treatment for Fine Lines, Crow's Feet & Sagging

"Two Weeks Is a Specific Claim. Clinical Numbers Behind It Make It Different from Every Other Eye Cream Making the Same Promise."

I've sat in enough undereye treatment consultations to have a particular relationship with numbers. What was measured. How many people. How long it took. When a brand says "visibly improves firmness" without anything behind it, I've learned to read past it. My name is Yua. I model in Seoul, I have mild edema that shows up in the morning without much consideration for my schedule, and my dermatologist and I have had the undereye conversation more than once.

The REJURAN Intensive Eye Cream gets my attention because of what it puts on record. 27.85% lifting improvement. 14.39% skin density improvement. 23.63% reduction in wrinkle depth. Measured clinically. In two weeks. The active behind those numbers is c-PDRN - a form of PDRN, the ingredient already used in professional aesthetic treatments, reformulated here as a topical cosmetic active. Hyaluronic acid, niacinamide, squalane, peptides alongside it. Paraben-free, sulfate-free, lightweight enough to go under makeup in the morning. For skin that needs results it can actually see, not feel, the construction here is worth understanding. 🥹

What is c-PDRN, and why does it appear in professional aesthetic treatments as well as skincare?

PDRN - Polydeoxyribonucleotide - is a bioactive compound derived from salmon DNA that has been used in aesthetic medicine for its tissue repair and regeneration properties. c-PDRN is REJURAN's cosmetic-grade version of this active, reformulated for topical application in skincare. In aesthetic clinic treatments, PDRN is administered via injection to support skin renewal and tissue density. As a topical active in an eye cream, c-PDRN is designed to deliver the same regeneration-supporting properties at the skin's surface level, without the clinical procedure. The clinical results from this formula - 27.85% lifting improvement and 14.39% skin density improvement in two weeks - are the measured outcomes of c-PDRN's topical function in the eye area specifically.

🥹 Yua's Note: PDRN (Polydeoxyribonucleotide) - a bioactive compound derived from purified salmon DNA fragments. In aesthetic medicine, it is known for supporting tissue repair, skin regeneration, and improving skin density. c-PDRN is the topical cosmetic-grade formulation of this active, designed for use in skincare products rather than injectable treatments. The "c" prefix indicates the cosmetic application format.

Also Worth Considering:

What do the three clinical measurements actually prove, and how were they obtained?

The clinical results are specific in both the metric and the timeline: 27.85% lifting improvement, 14.39% skin density improvement, and 23.63% reduction in wrinkle depth, measured after two weeks of use. These are not self-reported impressions from a consumer survey - they are measurements obtained through clinical testing instruments that quantify changes in lifting, density, and wrinkle depth objectively. The two-week timeline is notable because most eye cream clinical data is collected at four weeks. A measurable result at two weeks means the c-PDRN and peptide complex begins working before the standard clinical window. For skin concerns where visible change is the meaningful metric rather than how the product feels on application, instrument-measured results at a shorter timeline are a more useful data point than subjective consumer reporting.

What does niacinamide do specifically for dark circles in the eye area?

Dark circles have multiple causes - thin skin over blood vessels, pigmentation, loss of volume, and poor circulation all contribute. Niacinamide addresses the pigmentation component: it regulates melanin transfer between skin cells, which over time reduces the appearance of discolouration that creates or deepens dark circles. This is a gradual process measured in weeks rather than days. The c-PDRN and peptide combination in this formula addresses the structural side - improving skin density and lifting, which reduces the hollow shadow effect that makes dark circles more visible when the undereye area loses volume. Niacinamide and c-PDRN are therefore not duplicating each other - they are addressing different mechanisms that both contribute to the same visible concern.

🥹 Yua's Note: Melanin transfer - the process by which pigment-producing cells pass melanin to surrounding skin cells. Niacinamide works by interrupting this transfer, which gradually reduces the accumulation of pigment that causes uneven skin tone and visible darkening. In the undereye context, this addresses the pigmentation component of dark circles rather than the circulatory or structural component.

Also Worth Considering:

How does squalane in an eye cream differ from heavier eye cream emollients?

Eye cream emollients vary significantly in their texture and occlusion level. Heavier emollients - petrolatum-based or rich botanical butters - provide intense moisture but can migrate into the eye and blur vision, or feel heavy enough to interfere with makeup application. Squalane is a plant-derived oil that closely mirrors the skin's own sebum composition - it moisturises deeply without forming a heavy occlusive layer on the surface, absorbs quickly, and sits comfortably in the delicate eye area without migration risk. The formula is specifically described as lightweight and non-greasy with a silky finish. For morning use under makeup, squalane's fast absorption and non-greasy quality are the credentials that make the formula practical rather than just effective.

Is this suitable for sensitive skin, and is the eye area safe for daily morning and evening use?

The formula is confirmed suitable for all skin types including sensitive, with paraben-free, sulfate-free, and harmful-chemical-free formulation credentials. The eye area is the most sensitive skin on the face - thinner, with fewer sebaceous glands and greater reactivity. The lightweight texture is designed to absorb without irritation, and the formula is cruelty-free and clinically tested. For first use, a patch test on the inner arm before applying to the eye area is worth the 24 hours, particularly for sensitive skin types. The product's own safety information advises discontinuing use and consulting a specialist if redness, swelling, or itching occurs - standard guidance for any active-containing eye cream.

What Works

The Clinical Numbers Are Instrument-Measured, Not Self-Reported: 27.85% lifting improvement, 14.39% skin density improvement, 23.63% wrinkle depth reduction - all three are clinical measurements, not consumer survey responses. This distinction matters in the eye cream category specifically, where self-reported results are the norm and objectively measured improvements in lifting and density are significantly rarer. Two weeks is also a faster clinical timeline than the standard four-week result most eye creams cite.

c-PDRN Addresses Skin Density, Not Just Surface Hydration: Most eye creams work at the skin surface - moisturising, temporarily plumping, reflecting light. c-PDRN's clinical function, as reflected in the 14.39% skin density improvement measurement, addresses the structural layer where volume loss and thinning occur. For the undereye area where skin thins with age and this thinning makes dark circles and wrinkles more visible, a density improvement is a different kind of result from surface hydration.

Niacinamide and c-PDRN Are Targeting Different Parts of the Same Problem: Dark circles have a pigmentation component and a structural component. Niacinamide addresses melanin transfer for the pigmentation side. c-PDRN addresses density and lifting for the structural side. They are not redundant - they are complementary mechanisms working on the same visible concern from different angles simultaneously.

6-in-1 Wrinkle Care Means Multiple Eye Area Zones: The formula targets under-eye lines, crow's feet, and frown lines - three distinct wrinkle zones around the eye area that develop at different rates and from different causes. The peptide complex supporting the c-PDRN active is designed to address this range rather than concentrating benefit on one specific line type. For the eye area as a whole rather than one isolated concern, the coverage is broader than most single-active eye creams.

Lightweight Formula Applies Morning and Evening Without Interference: The squalane-based, non-greasy texture is confirmed suitable for morning use under makeup as well as evening use. The fast-absorbing, silky finish means no waiting window between application and the next skincare or makeup step. For a twice-daily active-containing eye cream, texture that doesn't disrupt the rest of the routine matters practically as much as what the formula achieves over time.

Patch Testing Before Eye Area Application: Even for sensitive-skin-suitable formulas, applying a new active - particularly one containing c-PDRN and peptides together - to the eye area without a prior tolerance check is a variable worth managing. Apply a small amount to the inner arm and wait 24 hours before the first full eye area application. The eye area's skin is the thinnest on the face and reactions that might be minimal elsewhere are more pronounced here.

*Clinical measurement at two weeks. c-PDRN behind the lifting number. Niacinamide working on the dark circle side while the peptides handle the structural side.

I don't need every eye cream to show dramatic results. I need the ones I use before a shoot to do something I can actually see in the morning light. Something with 27% lifting in the instrument reading is a product worth keeping in the routine.

The undereye area has always told the truth first. This is for when you want the truth to look a little better. 🥹*